Trials / Unknown
UnknownNCT03089411
Collection of Additional Data Followed the Study IFM 2013-04
Collection of Additional Data Followed the Study "A Phase III Study of Velcade (Bortezomib) Thalidomide Dexaméthasone (VTD) Versus Velcade (Bortezomib) Cyclophosphamide Dexaméthasone (VCD) as an Induction Treatment Prior to Autologous Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma"
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 340 (actual)
- Sponsor
- Nantes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 66 Years
- Healthy volunteers
- Not accepted
Summary
Collection of retrospective additional data (survival, biological, disease response data) following the study IFM 2013-04.
Conditions
Timeline
- Start date
- 2017-03-20
- Primary completion
- 2017-07-15
- Completion
- 2017-07-15
- First posted
- 2017-03-24
- Last updated
- 2017-03-27
Locations
63 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03089411. Inclusion in this directory is not an endorsement.